Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Putative E3 ubiquitin-protein ligase UNKL is a zinc finger protein classified within the RING finger family, encoded by the UNKL gene (also referred to as C16orf28, ZC3H5L, ZC3HDC5L, among other aliases)[1]. It is thought to function in Rac signaling pathways and mediates protein-protein interactions by binding to the Brg/Brm-associated factor 60b, promoting its ubiquitination—a process essential for protein turnover and regulation[1]. Multiple transcript variants arise due to alternative splicing. The protein features canonical zinc finger domains, notably the RING finger and CCCH motifs, commonly known for roles in nucleic acid binding and protein regulation. While not directly linked to major disease categories in curated databases, UNKL may be implicated in cell-regulatory processes relevant to disease progression, though specifics remain unclear[1]. No direct pharmacological agents, mechanisms of action, biomarkers, or safety concerns have been reported for UNKL as of current literature[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Putative E3 ubiquitin-protein ligase UNKL (UNKL).